Antitrust Litigation Antitrust Litigation
  • The Firm
  • Our Litigation
  • Investor Alerts
  • Contact Us
  • The Firm
  • Our Litigation
  • Investor Alerts
  • Contact Us

Antitrust Litigation

Morganti Legal’s Antitrust practice focuses on representing small-business owners and individuals who have been cheated by price-fixing and other forms of anti-competitive conduct.  Since 1999, Andrew Morganti has litigated many of the largest antitrust claims in the United States and Canada.  The product markets have included the airline industry, branded and generic pharmaceutical drugs, financial products, various types of groceries, industrial chemicals and products, internet services and eBooks, medical services, and telecommunications.

To discuss your legal matter with a lawyer in the Antitrust practice at no cost and with no obligation, contact us today.

     

    Recent News

    • Wayland Group Corp. (F/K/A, Maricann): Ontario Court Grants Access to the Court to Investors
    • Wayland Group Corp. (f/k/a, Maricann): Quebec Court Quick to Protect Québécois Investors
    • Ontario Division Court unanimously agrees to allow investors’ claims to advance against Auxly Cannabis Group, Inc.
    • U.S. Securities and Exchange Commission Warns Investors investing in China-based companies
    • Intellipharmaceutics International, Inc., Shareholder Class Certification and Settlement
    Morganti & CO., P.L.C. (Michigan, United States)

    Disclaimer / Terms of Use
    Morganti & CO., P.C. (Ontario, Canada)
    en English
    ar العربيةzh-CN 简体中文nl Nederlandsen Englishfr Françaisde Deutschit Italianopt Portuguêsru Русскийes Español
    Register

      For the shares purchased during the identified "class period", those shares are automatically considered to be included within the proceeding. For shares purchased outside of the identified "class period", those are not automatically included and you may be required to retain your own lawyer.

      We welcome you to complete the below form so you can receive future updates about the proceeding. If you invested more than $50,000, in the particular investment, please complete the form and we will contact you within the near future.